GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT00776802 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of funding

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: GCS-100
DRUG: Etoposide; Dexamethasone

Sponsor

La Jolla Pharmaceutical Company